第二类 | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Buprenorphine Transdermal patch |
|
| | | Butorphanol and its injection | | | | | | | | | | |
| | | | | | | | | Dezocine and Its Injection | | | | | Ergotamine and Caffeine Tablet | | | | | | | | | | | | | | | Nalbuphine and its injection | | | | | Paracetamol and Hydrocodone Bitartrate Tablet |
| | | | | | | | | | |
| | | | | | | | | | |
注:1.上述品种包括其可能存在的盐和单方制剂(除非另有规定)。 2.上述品种包括其可能存在的异构体(除非另有规定)。 3.品种目录有*的精神药品为我国生产及使用的品种。
|